Search
Now showing items 1-6 of 6
The prevalence and predictors of health unit delivery among HIV positive pregnant women who attend ANC at Mulago Hospital
(2012-05)
About 700,000 children in 2005 were infected with HIV worldwide virtually all of them through mother to child transmission (MTCT). About 90% of them occurred in sub-Saharan Africa due to a continuation of the high prevalence ...
Barriers to timely antiretroviral therapy initiation among HIV infected children attending TASO clinics at Tororo, Mulago and Jinja
(Makerere University, 2014-02-20)
Background: statistics show an increase in the prevalence and incidence of HIV among children yet these figures do not match with the numbers on treatment. Records showed evidence of delayed ART initiation (initiation ...
Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Uganda.
(Elsevier Ireland, 2013)
Objective: To determine factors associated with an unknown HIV serostatus among pregnantwomen admitted in
labor to Mulago Hospital, Kampala, Uganda. Methods: In total, 665 pregnant women admitted to Mulago Hospital
were ...
Factors affecting utilization of natal services by HIV pregnant women in Jnja District, Uganda.
(2009-07)
BACKGROUND:
The Uganda MoH policy on PMTCT requires all HIV positive pregnant women to deliver in higher facilities to access nevirapine and modified obstetrical care in order to reduce MTCT. However, only 34% of the HIV ...
Use of modern family planning methods among HIV positive mothers attending mother baby care points at health facilities in Kabarole District Uganda
(Makerere University, 2017)
Background: Preventing unintended pregnancies among women living with HIV is an important component in the elimination of mother-to-child HIV transmission (eMTCT) and enhancement of maternal health outcomes. Despite increased ...
Tenofovir related renal toxicity monitoring in antiretroviral therapy (ART) accredited sites: A situational analysis for Uganda
(Makerere University, 2014-09)
Background: In Uganda, Tenofovir-based regimen is recommended as first line particularly for HIV/AIDS adult and adolescent patient and for option B+ in prevention of mother-to-child transmission (PMTCT). As a result of ...